ArticleProceedings of the National Academy of Sciences of the United States of America2017

In vivo loss-of-function screens identify KPNB1 as a new druggable oncogene in epithelial ovarian cancer.

Michiko Kodama et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.